<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-pharmaceutics-12-00171">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Iyengar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tay-Teo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Vogler</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Beyer</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Wiktor</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>de Joncheere</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hill</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis</article-title>
  <source>PLoS Med.</source>
  <year>2016</year>
  <volume>13</volume>
  <elocation-id>e1002032</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pmed.1002032</pub-id>
  <pub-id pub-id-type="pmid">27243629</pub-id>
 </element-citation>
</ref>
